Opthea (OPT) Q3 2026 TU earnings summary

Executive summary

• Initiated the OPT-302 LAM development program with feasibility studies and focused on re-engagement with the ASX for securities reinstatement.

• Continued operational progress following a strategic review completed in December 2025.

Financial highlights

• Held AUD $31.2 million in cash and equivalents at 31 March 2026, down from AUD $33.2 million at 31 December 2025.

• Operating cash outflow for the quarter was AUD $1.5 million, compared to a prior quarter inflow of AUD $6.3 million (driven by a one-time AUD $10.8 million R&D Tax Incentive in the previous quarter).

• Research and development expenses were AUD $0.2 million; administration expenses AUD $1.1 million; personnel expenses were nil.

• Payments to Directors totaled AUD $0.2 million for the quarter.

• Net cash used in operating activities for the quarter was AUD $1.47 million; for the nine months, AUD $11.38 million.

Outlook and guidance

• Will continue to update the market as the LAM program progresses and milestones are reached.

• Plans to seek reinstatement of securities on the ASX in the first half of calendar year 2026.